Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2008

Conditions
Carotid Artery Stenosis
Interventions
DEVICE

Smart nitinol stent implantation

Before intervention, clopidogrel (75 mg/d), aspirin (100 mg/d) and atorvastatin (40 mg/d) were prescribed. One week later, aortic arch and aortocranial angiography were performed under general anesthesia to determine the site, range and extent of the lesion and the status of the cerebral microcirculation, and consequently to inform the treatment strategy and the selection of the correct size of self-expanding nitinol stent system.

DRUG

antiplatelet drug

Patients with carotid artery stenosis treated conservatively were commenced on an indefinite course of one or more oral antiplatelet drugs. The antiplatelet regimes comprised 100 mg or 300 mg aspirin before sleep with clopidogrel 125 mg or 250 mg daily; or 75 mg clopidogrel before sleep daily.

All Listed Sponsors
lead

Beijing Jishuitan Hospital

OTHER

NCT02800174 - Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis | Biotech Hunter | Biotech Hunter